Journal of Hematology & Oncology · 2021 · 182 citations · 36 references
MedicineCancer BiologyOncologyCarcinogenesisGene ExpressionMolecular OncologyCancer BiomarkersCancer Cell SignalingCancer Molecular PathologyCancer TranscriptomicsNext-generation Sequencing In OncologyNoncoding Rna In CancerMalignant ProgressionMrna Degradation PathwaysN6-methyladenosine RegulationNf-κb SignalingOncogenic TransformationOrthotopic Tumor ModelsQuantitative Polymerase Chain ReactionRna Immunoprecipitation
Abstract Background The prognosis for diffuse gliomas is very poor and the mechanism underlying their malignant progression remains unclear. Here, we aimed to elucidate the role and mechanism of the RNA N 6,2′- O -dimethyladenosine (m 6 A) reader, YTH N 6-methyladenosine RNA binding protein 2 (YTHDF2), in regulating the malignant progression of gliomas. Methods YTHDF2 mRNA levels and functions were assessed using several independent datasets. Western blotting, quantitative polymerase chain reaction, and immunohistochemistry were used to evaluate the expression levels of YTHDF2 and other molecules in human and mouse tumor tissues and cells. Knockdown and overexpression were used to evaluate the effects of YTHDF2, methyltransferase-like 3 (METTL3), and UBX domain protein 1 (UBXN1) on glioma malignancy in cell and orthotopic xenograft models. RNA immunoprecipitation (RIP), methylated RIP, and RNA stability experiments were performed to study the mechanisms underlying the oncogenic role of YTHDF2. Results YTHDF2 expression was positively associated with a higher malignant grade and molecular subtype of glioma and poorer prognosis. YTHDF2 promoted the malignant progression of gliomas in both in vitro and in vivo models. Mechanistically, YTHDF2 accelerated UBXN1 mRNA degradation via METTL3-mediated m 6 A, which, in turn, promoted NF-κB activation. We further revealed that UBXN1 overexpression attenuated the oncogenic effect of YTHDF2 overexpression and was associated with better survival in patients with elevated YTHDF2 expression. Conclusions Our findings confirmed that YTHDF2 promotes the malignant progression of gliomas and revealed important insight into the upstream regulatory mechanism of NF-κB activation via UBXN1 with a primary focus on m 6 A modification.
36
Metascape provides a biologist-oriented resource for the analysis of systems-level datasets
Yingyao Zhou, Bin Zhou, Lars Pache et al. · Nature Communications · 2019 · 15.6K citations · Full text
N6-methyladenosine-dependent regulation of messenger RNA stability
Xiao Wang, Zhike Lu, Adrian Gomez-Nguyen et al. · Nature · 2013 · 4.8K citations
Hao Du, Ya Zhao, Jinqiu He et al. · Nature Communications · 2016 · 1.5K citations · Full text
m6A RNA Methylation Regulates the Self-Renewal and Tumorigenesis of Glioblastoma Stem Cells
Qi Cui, Hailing Shi, Peng Ye et al. · Cell Reports · 2017 · 1.3K citations · Full text
Medicine, Cancer Biology, Oncology +17
R-2HG Exhibits Anti-tumor Activity by Targeting FTO/m6A/MYC/CEBPA Signaling
Rui Su, Lei Dong, Chenying Li et al. · Cell · 2017 · 1.2K citations · Full text
Medicine, Oncology, Pharmacology +10